ARHG6_HUMAN - dbPTM
ARHG6_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID ARHG6_HUMAN
UniProt AC Q15052
Protein Name Rho guanine nucleotide exchange factor 6
Gene Name ARHGEF6
Organism Homo sapiens (Human).
Sequence Length 776
Subcellular Localization Cell projection, lamellipodium.
Protein Description Acts as a RAC1 guanine nucleotide exchange factor (GEF)..
Protein Sequence MNPEEQIVTWLISLGVLESPKKTICDPEEFLKSSLKNGVVLCKLINRLMPGSVEKFCLDPQTEADCINNINDFLKGCATLQVEIFDPDDLYSGVNFSKVLSTLLAVNKATEDQLSERPCGRSSSLSAANTSQTNPQGAVSSTVSGLQRQSKTVEMTENGSHQLIVKARFNFKQTNEDELSVCKGDIIYVTRVEEGGWWEGTLNGRTGWFPSNYVREIKSSERPLSPKAVKGFETAPLTKNYYTVVLQNILDTEKEYAKELQSLLVTYLRPLQSNNNLSTVEVTSLLGNFEEVCTFQQTLCQALEECSKFPENQHKVGGCLLSLMPHFKSMYLAYCANHPSAVNVLTQHSDELEQFMENQGASSPGILILTTNLSKPFMRLEKYVTLLQELERHMEDTHPDHQDILKAIVAFKTLMGQCQDLRKRKQLELQILSEPIQAWEGEDIKNLGNVIFMSQVMVQYGACEEKEERYLMLFSNVLIMLSASPRMSGFIYQGKIPIAGTVVTRLDEIEGNDCTFEITGNTVERIVVHCNNNQDFQEWLEQLNRLIRGPASCSSLSKTSSSSCSAHSSFSSTGQPRGPLEPPQIIKPWSLSCLRPAPPLRPSAALGYKERMSYILKESSKSPKTMKKFLHKRKTERKPSEEEYVIRKSTAALEEDAQILKVIEAYCTSANFQQGHGSSTRKDSIPQVLLPEEEKLIIEETRSNGQTIMEEKSLVDTVYALKDEVRELKQENKRMKQCLEEELKSRRDLEKLVRRLLKQTDECIRGESSSKTSILP
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
19PhosphorylationISLGVLESPKKTICD
HHHCCCCCCCCCCCC
37.5524719451
22UbiquitinationGVLESPKKTICDPEE
CCCCCCCCCCCCHHH
46.65-
32UbiquitinationCDPEEFLKSSLKNGV
CCHHHHHHHHCCCCH
43.23-
43UbiquitinationKNGVVLCKLINRLMP
CCCHHHHHHHHHHCC
48.52-
91PhosphorylationIFDPDDLYSGVNFSK
ECCHHHCCCCCCHHH
15.4622817900
101PhosphorylationVNFSKVLSTLLAVNK
CCHHHHHHHHHHHCC
21.7230576142
102PhosphorylationNFSKVLSTLLAVNKA
CHHHHHHHHHHHCCC
22.9426074081
108UbiquitinationSTLLAVNKATEDQLS
HHHHHHCCCCHHHHC
50.52-
122PhosphorylationSERPCGRSSSLSAAN
CCCCCCCCCCCCCCC
15.0123401153
123PhosphorylationERPCGRSSSLSAANT
CCCCCCCCCCCCCCC
33.6615570572
124PhosphorylationRPCGRSSSLSAANTS
CCCCCCCCCCCCCCC
27.8223911959
126PhosphorylationCGRSSSLSAANTSQT
CCCCCCCCCCCCCCC
27.5521082442
130PhosphorylationSSLSAANTSQTNPQG
CCCCCCCCCCCCCCC
19.9328450419
131PhosphorylationSLSAANTSQTNPQGA
CCCCCCCCCCCCCCC
34.5128450419
133PhosphorylationSAANTSQTNPQGAVS
CCCCCCCCCCCCCHH
48.9419690332
140PhosphorylationTNPQGAVSSTVSGLQ
CCCCCCHHHHHHHHH
21.5419690332
141PhosphorylationNPQGAVSSTVSGLQR
CCCCCHHHHHHHHHH
26.6528450419
142PhosphorylationPQGAVSSTVSGLQRQ
CCCCHHHHHHHHHHC
15.9319690332
144PhosphorylationGAVSSTVSGLQRQSK
CCHHHHHHHHHHCCC
33.6021082442
150PhosphorylationVSGLQRQSKTVEMTE
HHHHHHCCCEEEECC
32.2723401153
151UbiquitinationSGLQRQSKTVEMTEN
HHHHHCCCEEEECCC
48.53-
152PhosphorylationGLQRQSKTVEMTENG
HHHHCCCEEEECCCC
27.2628122231
166UbiquitinationGSHQLIVKARFNFKQ
CCEEEEEEEEEEECC
27.18-
188PhosphorylationVCKGDIIYVTRVEEG
EECCCEEEEEEEEEC
8.9729978859
190PhosphorylationKGDIIYVTRVEEGGW
CCCEEEEEEEEECCE
16.4229978859
201PhosphorylationEGGWWEGTLNGRTGW
ECCEEEEEECCCCCE
12.9224076635
219PhosphorylationNYVREIKSSERPLSP
HHHHHHHCCCCCCCH
42.9930266825
220PhosphorylationYVREIKSSERPLSPK
HHHHHHCCCCCCCHH
32.4026657352
225PhosphorylationKSSERPLSPKAVKGF
HCCCCCCCHHHCCCC
27.3423401153
227UbiquitinationSERPLSPKAVKGFET
CCCCCCHHHCCCCCC
63.54-
230UbiquitinationPLSPKAVKGFETAPL
CCCHHHCCCCCCCCC
63.84-
234PhosphorylationKAVKGFETAPLTKNY
HHCCCCCCCCCCCCC
31.1726074081
254UbiquitinationQNILDTEKEYAKELQ
HHHHHCHHHHHHHHH
59.11-
382UbiquitinationKPFMRLEKYVTLLQE
CCHHHHHHHHHHHHH
50.00-
406UbiquitinationPDHQDILKAIVAFKT
CCHHHHHHHHHHHHH
36.08-
412UbiquitinationLKAIVAFKTLMGQCQ
HHHHHHHHHHHHHHH
30.89-
454PhosphorylationLGNVIFMSQVMVQYG
HHHEEHHEEEHHHHC
14.6320068231
460PhosphorylationMSQVMVQYGACEEKE
HEEEHHHHCCCCCHH
8.6920068231
470PhosphorylationCEEKEERYLMLFSNV
CCCHHHHHHHHHHCH
10.3520068231
475PhosphorylationERYLMLFSNVLIMLS
HHHHHHHHCHHHHHC
23.2824719451
482PhosphorylationSNVLIMLSASPRMSG
HCHHHHHCCCCCCCC
14.8820068231
484PhosphorylationVLIMLSASPRMSGFI
HHHHHCCCCCCCCCE
15.0620068231
488PhosphorylationLSASPRMSGFIYQGK
HCCCCCCCCCEECCC
31.6519664994
492PhosphorylationPRMSGFIYQGKIPIA
CCCCCCEECCCCCCC
14.6730266825
495UbiquitinationSGFIYQGKIPIAGTV
CCCEECCCCCCCCEE
29.77-
504PhosphorylationPIAGTVVTRLDEIEG
CCCCEEEEEHHHCCC
22.60-
552PhosphorylationRLIRGPASCSSLSKT
HHHHCCCCCCCCCCC
20.0526552605
554PhosphorylationIRGPASCSSLSKTSS
HHCCCCCCCCCCCCC
31.6426552605
555PhosphorylationRGPASCSSLSKTSSS
HCCCCCCCCCCCCCC
40.7826552605
557PhosphorylationPASCSSLSKTSSSSC
CCCCCCCCCCCCCCC
35.5226552605
558UbiquitinationASCSSLSKTSSSSCS
CCCCCCCCCCCCCCC
58.69-
559PhosphorylationSCSSLSKTSSSSCSA
CCCCCCCCCCCCCCC
30.3928450419
560PhosphorylationCSSLSKTSSSSCSAH
CCCCCCCCCCCCCCC
31.7728450419
561PhosphorylationSSLSKTSSSSCSAHS
CCCCCCCCCCCCCCC
31.3528450419
562PhosphorylationSLSKTSSSSCSAHSS
CCCCCCCCCCCCCCC
34.8228450419
563PhosphorylationLSKTSSSSCSAHSSF
CCCCCCCCCCCCCCC
17.6528450419
565PhosphorylationKTSSSSCSAHSSFSS
CCCCCCCCCCCCCCC
30.8528450419
568PhosphorylationSSSCSAHSSFSSTGQ
CCCCCCCCCCCCCCC
32.5628450419
569PhosphorylationSSCSAHSSFSSTGQP
CCCCCCCCCCCCCCC
21.2028450419
571PhosphorylationCSAHSSFSSTGQPRG
CCCCCCCCCCCCCCC
29.0123312004
572PhosphorylationSAHSSFSSTGQPRGP
CCCCCCCCCCCCCCC
34.2527251275
573PhosphorylationAHSSFSSTGQPRGPL
CCCCCCCCCCCCCCC
38.3423312004
592PhosphorylationIIKPWSLSCLRPAPP
CCCCCCCHHCCCCCC
12.9418491316
608PhosphorylationRPSAALGYKERMSYI
CCCHHCCHHHHHHHH
15.5522210691
613PhosphorylationLGYKERMSYILKESS
CCHHHHHHHHHHHCC
18.4224275569
614PhosphorylationGYKERMSYILKESSK
CHHHHHHHHHHHCCC
10.8323312004
617UbiquitinationERMSYILKESSKSPK
HHHHHHHHHCCCCHH
46.09-
619PhosphorylationMSYILKESSKSPKTM
HHHHHHHCCCCHHHH
41.2926074081
620PhosphorylationSYILKESSKSPKTMK
HHHHHHCCCCHHHHH
37.9426074081
622PhosphorylationILKESSKSPKTMKKF
HHHHCCCCHHHHHHH
33.3126074081
625PhosphorylationESSKSPKTMKKFLHK
HCCCCHHHHHHHHHH
37.2926074081
627AcetylationSKSPKTMKKFLHKRK
CCCHHHHHHHHHHCC
45.6830587013
635PhosphorylationKFLHKRKTERKPSEE
HHHHHCCCCCCCCHH
45.0926074081
638UbiquitinationHKRKTERKPSEEEYV
HHCCCCCCCCHHHHH
46.81-
640PhosphorylationRKTERKPSEEEYVIR
CCCCCCCCHHHHHHH
61.7522617229
644PhosphorylationRKPSEEEYVIRKSTA
CCCCHHHHHHHHHHH
12.4023927012
648UbiquitinationEEEYVIRKSTAALEE
HHHHHHHHHHHHHHH
40.82-
649PhosphorylationEEYVIRKSTAALEED
HHHHHHHHHHHHHHH
17.2729255136
650PhosphorylationEYVIRKSTAALEEDA
HHHHHHHHHHHHHHH
20.9830266825
661UbiquitinationEEDAQILKVIEAYCT
HHHHHHHHHHHHHHH
42.68-
666PhosphorylationILKVIEAYCTSANFQ
HHHHHHHHHHHCCCC
5.4028796482
668PhosphorylationKVIEAYCTSANFQQG
HHHHHHHHHCCCCCC
20.4227080861
669PhosphorylationVIEAYCTSANFQQGH
HHHHHHHHCCCCCCC
20.0423882029
678PhosphorylationNFQQGHGSSTRKDSI
CCCCCCCCCCCCCCC
23.9029978859
679PhosphorylationFQQGHGSSTRKDSIP
CCCCCCCCCCCCCCC
36.5029978859
680PhosphorylationQQGHGSSTRKDSIPQ
CCCCCCCCCCCCCCC
43.3627080861
682UbiquitinationGHGSSTRKDSIPQVL
CCCCCCCCCCCCCCC
56.78-
684PhosphorylationGSSTRKDSIPQVLLP
CCCCCCCCCCCCCCC
38.9229255136
695UbiquitinationVLLPEEEKLIIEETR
CCCCHHHHEEEEEHH
48.54-
701PhosphorylationEKLIIEETRSNGQTI
HHEEEEEHHHCCCEE
26.9728450419
703PhosphorylationLIIEETRSNGQTIME
EEEEEHHHCCCEEEE
53.3719664995
712UbiquitinationGQTIMEEKSLVDTVY
CCEEEEEHHHHHHHH
35.46-
713PhosphorylationQTIMEEKSLVDTVYA
CEEEEEHHHHHHHHH
36.5828555341
717PhosphorylationEEKSLVDTVYALKDE
EEHHHHHHHHHHHHH
14.1329978859
719PhosphorylationKSLVDTVYALKDEVR
HHHHHHHHHHHHHHH
14.3329978859
722UbiquitinationVDTVYALKDEVRELK
HHHHHHHHHHHHHHH
43.61-
736UbiquitinationKQENKRMKQCLEEEL
HHHHHHHHHHHHHHH
41.72-
744AcetylationQCLEEELKSRRDLEK
HHHHHHHHHHHHHHH
45.2425953088
751AcetylationKSRRDLEKLVRRLLK
HHHHHHHHHHHHHHH
60.6319608861
758UbiquitinationKLVRRLLKQTDECIR
HHHHHHHHHCCHHHC
56.60-

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources
225SPhosphorylationKinasePRKCQQ04759
GPS
488SPhosphorylationKinasePRKCQQ04759
GPS
684SPhosphorylationKinasePRKACAP17612
GPS
684SPhosphorylationKinasePRKG1Q13976
GPS

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference

Oops, there are no descriptions of PTM sites of ARHG6_HUMAN !!

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of ARHG6_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
ZN580_HUMANZNF580physical
21900206
PAK1_HUMANPAK1physical
21900206
GIT1_HUMANGIT1physical
21900206
GASP2_HUMANGPRASP2physical
21900206
SH3G3_HUMANSH3GL3physical
21900206
TM108_HUMANTMEM108physical
21900206
PRKDC_HUMANPRKDCphysical
19918261
ARHG7_HUMANARHGEF7physical
15306850
ARHG6_HUMANARHGEF6physical
15306850
TGFR1_HUMANTGFBR1physical
15761153
TGFR2_HUMANTGFBR2physical
15761153
CBL_HUMANCBLphysical
26177020
GIT1_HUMANGIT1physical
28514442
FBX28_HUMANFBXO28physical
28514442
PAK1_HUMANPAK1physical
28514442
PAK2_HUMANPAK2physical
28514442
UBP7_HUMANUSP7physical
28514442
NHRF2_HUMANSLC9A3R2physical
27173435

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
300436Mental retardation, X-linked 46 (MRX46)
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of ARHG6_HUMAN

loading...

Related Literatures of Post-Translational Modification
Acetylation
ReferencePubMed
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions.";
Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.;
Science 325:834-840(2009).
Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-751, AND MASS SPECTROMETRY.
Phosphorylation
ReferencePubMed
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions.";
Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.;
Sci. Signal. 2:RA46-RA46(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-126; SER-144; SER-150;TYR-188; SER-488; SER-640 AND SER-684, AND MASS SPECTROMETRY.
"Large-scale proteomics analysis of the human kinome.";
Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,Mann M., Daub H.;
Mol. Cell. Proteomics 8:1751-1764(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-488, AND MASSSPECTROMETRY.
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach.";
Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.;
Anal. Chem. 81:4493-4501(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-684, AND MASSSPECTROMETRY.
"A quantitative atlas of mitotic phosphorylation.";
Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.;
Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-488, AND MASSSPECTROMETRY.
"Combining protein-based IMAC, peptide-based IMAC, and MudPIT forefficient phosphoproteomic analysis.";
Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D.,Yates J.R. III;
J. Proteome Res. 7:1346-1351(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-488, AND MASSSPECTROMETRY.
"A probability-based approach for high-throughput proteinphosphorylation analysis and site localization.";
Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.;
Nat. Biotechnol. 24:1285-1292(2006).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-488, AND MASSSPECTROMETRY.
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks.";
Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.;
Cell 127:635-648(2006).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-488, AND MASSSPECTROMETRY.
"Quantitative phosphoproteome analysis using a dendrimer conjugationchemistry and tandem mass spectrometry.";
Tao W.A., Wollscheid B., O'Brien R., Eng J.K., Li X.-J.,Bodenmiller B., Watts J.D., Hood L., Aebersold R.;
Nat. Methods 2:591-598(2005).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-225 AND SER-684, ANDMASS SPECTROMETRY.
"Large-scale characterization of HeLa cell nuclear phosphoproteins.";
Beausoleil S.A., Jedrychowski M., Schwartz D., Elias J.E., Villen J.,Li J., Cohn M.A., Cantley L.C., Gygi S.P.;
Proc. Natl. Acad. Sci. U.S.A. 101:12130-12135(2004).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-488, AND MASSSPECTROMETRY.

TOP